User Bar First

This is a debugging block

User Bar Second

This is a debugging block

Header First

This is a debugging block

Header Second

This is a debugging block

Preface First

This is a debugging block

Preface Second

This is a debugging block

Preface Third

This is a debugging block

MAJORITY WHIPLINE: WEDNESDAY, APRIL 14, 2021

Content

This is a debugging block

House Meets at… Votes Predicted at…
10:00 a.m. Morning Hour
12:00 p.m. Legislative Business
First/Last Votes: 4:30 p.m. – 6:00 p.m.

 

ANY ANTICIPATED MEMBER ABSENCES FOR VOTES TODAY SHOULD BE REPORTED IMMEDIATELY TO THE OFFICE OF THE MAJORITY WHIP AT 6-3210.

Floor Schedule and Procedure:

Suspensions (17 bills)

1.H.R. 172 – United States Anti-Doping Agency Reauthorization Act of 2021 (Rep. Thompson (CA) – Energy and Commerce)

This bill authorizes the U.S. Anti-Doping Agency (USADA) through the end of fiscal year 2030.  The bill directs USADA to promote positive youth sports experiences by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports.  It also directs the Department of Justice, the Department of Homeland Security, and the FDA to coordinate with USADA efforts to prevent the use of performance-enhancing drugs or prohibit performance-enhancing methods by sharing certain information.

2. S. 578 – FASTER Act of 2021 (Sen. Scott (SC) – Energy and Commerce)

This legislation amends the Federal Food, Drug, and Cosmetic Act to include sesame as a major allergen. The legislation also requires HHS to issue a report describing ongoing federal activities related to food allergies, including food allergy treatment, surveillance, and risk reduction, and requires HHS to provide recommendations and strategies to improve, enhance, or expand these activities. Specifically, the legislation requires HHS to provide recommendations for the development and implementation of a regulatory process and framework to allow FDA to modify the definition of “major food allergen.”

3. H.R. 189 – John Lewis NIMHD Research Endowment Revitalization Act of 2021 (Rep. Barragan – Energy and Commerce)

This bill authorizes the National Institute on Minority Health and Health Disparities to facilitate research on minority health disparities through research endowments at current or former centers of excellence.

4. H.R. 941 – TRANSPLANT Act of 2021 (Rep. Matsui – Energy and Commerce)

This bill reauthorizes the C.W. Bill Young Transplantation Program (the Program) at $31 million each year from fiscal year (FY) 2022 through FY 2026.  The bill also requires Health Resources and Services Administration’s (HRSA) Advisory Council on Blood Stem Cell Transplantation to meet at least twice a year and requires the Department of Health and Human Services (HHS) to review the state of the science related to adult stem cells and birthing tissues for the purpose of potentially including these innovative therapies in the Program.  In addition, the bill would reauthorize the cord blood inventory program under the Stem Cell Therapeutic and Research Act of 2005 at level funding of $23 million for each year from FY 2022 through FY 2026.

5. S. 164 – Advancing Education on Biosimilars Act of 2021 (Sen. Hassan – Energy and Commerce)

This bill would require the U.S. Food and Drug Administration (FDA) to create a public website to educate patients and providers about biological and biosimilar products, and how to report on any risks to patient health and safety.

6. S. 415 – To amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity (Sen. Cassidy – Energy and Commerce)

Clarifies the eligibility for five-year new chemical entity (NCE) exclusivity is only available for a drug containing no active moiety that has been previously approved in the United States.  Ensures that drug manufacturers cannot receive NCE exclusivity for making small tweaks to old drugs – and that only the most innovative or novel drugs qualify for exclusivity.

7. H.R. 1215 – Fraud and Scam Reduction Act, as amended (Rep. Blunt Rochester – Energy and Commerce)

This bill establishes a senior scams prevention advisory group at the FTC to improve educational materials on senior scams. This bill also establishes an advisory office for senior scams at the FTC.

8. H.R. 1460 – Nicholas and Zachary Burt Memorial Carbon Monoxide Poisoning Prevention Act of 2021 (Rep. Kuster – Energy and Commerce)

H.R. 1460 directs the Consumer Product Safety Commission (CPSC) to establish a grant program for states to purchase and install carbon monoxide detectors in dwelling units of low-income families or the elderly; facilities that commonly serve children or the elderly, including childcare facilities, public schools, and senior centers; or student dorms owned by public universities, and to assist in enforcement and education efforts related to carbon monoxide detectors.

9. H.R. 446 – Protecting Seniors from Emergency Scams (Rep. Kelly (IL) – Energy and Commerce)

This bill requires an FTC report on seniors scams.

10. H.R. 1762 – Protecting Indian Tribes from Scams Act (Rep. Mullin – Energy and Commerce)

This bill requires an FTC report on scams targeted at Indian Tribes and members of Indian Tribes.

11. H.R. 1766 – FTC Collaboration Act of 2021 (Rep. O’Halleran – Energy and Commerce)

This bill requires an FTC report on collaboration between the FTC and state AGs regarding scam enforcement.

12. H.R. 1002 – DEBAR Act of 2021, as amended (Rep. Latta – Energy and Commerce)

This bill would amend the Controlled Substances Act to allow the Attorney General to prohibit any registrant from manufacturing, distributing, or dispensing a controlled substance or a list I chemical if that registrant meets or has met any of the conditions for suspension or revocation of registration under subsection (a) of the Act, or has a history of prior suspension or revocations.

13. H.R. 1899 – Ensuring Compliance Against Drug Diversion Act of 2021 (Rep. Griffith – Energy and Commerce)

This bill terminates the controlled substance registration of any registrant if the registrant dies, ceases legal existence, discontinues business or professional practice, or surrenders registration. A registrant who ceases legal existence or discontinues business is required to notify Drug Enforcement Administration (DEA). Registrants must receive written consent from DEA in order to assign or transfer a registration. Registrants are also required to return certain documentation if a registrant’s work is discontinued.

14. H.R. 1502 – Microloan Improvement Act of 2021 (Rep. Kim (NJ) – Small Business)

This bill amends the Small Business Act to modernize the SBA’s microloan program to provide greater technical and financial assistance to small businesses.

15. H.R. 1487 – Microloan Transparency and Accountability Act of 2021 (Rep. Burchett – Small Business)

This bill amends the Small Business Act to modify provisions related to the disbursement of funds through the microloan program and strengthens the program for rural small businesses.

16. H.R. 1490 – 504 Modernization and Small Manufacturer Enhancement Act of 2021 (Rep. Craig – Small Business)

This bill amends the Small Business Investment Act to increase the maximum loan amount for manufacturing loans from $5.5 million to $6.5 million, increases SBA outreach to small manufacturers, and streamlines the administrative closing process for 504 loans.

17. H.R. 1482 – 504 Credit Risk Management Improvement Act of 2021 (Rep. Bishop (NC) – Small Business)

This bill amends the Small Business Investment Act to shift loan closing file review responsibilities to the Small Business Administration’s (SBA) Office of Credit Risk Management (OCRM).

H.Res. 303 – Rule Providing for Consideration of H.R. 7 – Paycheck Fairness Act (Rep. DeLauro – Education and Labor) and H.R. 1195 – Workplace Violence Prevention for Health Care and Social Service Workers Act (Rep. Courtney – Education and Labor)

                   

QUOTE OF THE DAY:

“Something which we think is impossible now is not impossible in another decade.” 

Constance Baker Motley

Postscript First

This is a debugging block

Postscript Second

This is a debugging block

Postscript Third

This is a debugging block

Postscript Fourth

This is a debugging block